Lisa Lynn Decker - 29 Nov 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Business Officer
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
29 Nov 2023
Net transactions value
-$7,331
Form type
4
Filing time
01 Dec 2023, 19:01:53 UTC
Previous filing
25 May 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS 11/29/2023 Sale $7,331 -1,180 -2.9% $6.21 40,001 29 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $5.79 to $6.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.